Full Court deals drug companies a blow on patent term extensions
The Full Court has upheld two judgments that shortened patent term extensions granted to Merck Sharpe & Dohme and Ono Pharmaceuticals, finding the extension regime cannot be construed as achieving a “commercial outcome for a patentee”.
For information on rights and reprints, contact subscriptions@lawyerly.com.au